Applicant
Fisher & Paykel Healthcare Properties Limited
Case number(s)
202200414
Decision date
Type
Decision
DecisionConsent granted
Decision makerThe Minister for Land Information and the Associate Minister of Finance
Decision date26 April 2023
Pathway(s)Benefit to New Zealand (Benefit to New Zealand - Farm land) and Significant Business Assets
InvestmentAn overseas investment in sensitive land, being the Applicant's acquisition of a freehold interest in approximately 104.2612 hectares of land at Karaka, South Auckland. 
Consideration$275,000,000
ApplicantFisher & Paykel Healthcare Properties Limited
New Zealand (34%)
Australia (32%)
North America Region (15%)
United Kingdom (9%)
Various (10%)
VendorKaraka Meadows Limited
New Zealand (100%)
Background

The Applicant is part of the Fisher & Paykel Healthcare Group which has been headquartered in New Zealand since 1969. The Group operates a research and development and manufacturing campus in East, Tamaki, Auckland. The land is currently used primarily for pastural purposes including grazing and horticulture (a tomato hot house business) and a lease to a refrigerated produce transport business.

The Applicant's existing campus is nearing capacity, so the Applicant is acquiring the land for the purpose of constructing a second research and development and manufacturing campus.  Operations will include research and development activities, pilot manufacturing, and associate commercial and administration services.

This will enable and support ongoing expansion of the Applicant's business activities in New Zealand. The campus will be constructed in three phases with completion of the first phase anticipated to be complete in 2029.

The main benefits to New Zealand from phase one of the development are likely to include economic benefits via significant capital expenditure of approximately $230–300 million, the creation of 300–600 permanent FTE jobs along with hundreds of temporary construction roles, development of new technology, increased productivity and increased export receipts.  The investment is also likely to advance the Government’s Research, Science and Innovation Strategy, Economic Plan and Employment Strategy.

Consent was granted as the Applicant met the investor test criterion and that the benefit likely to occur as a result of the Investment would result in benefit to New Zealand.

More informationAndrew Monteith
MinterEllisonRuddWatts
PwC Tower 15 Customs Street West
Auckland 1010

See the attached assessment report linked below, which was published in response to an Official Information Act request:

Overseas investment assessment reports for case numbers 202200068, 202200414, 201900377 and 201900621

Related files